Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers
- 14 September 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (40), 17024-17038
- https://doi.org/10.1021/jacs.0c06400
Abstract
Broad-spectrum antivirals are powerful weapons against dangerous viruses where no specific therapy exists, as in the case of the ongoing SARS-CoV-2 pandemic. We discovered that a lysine- and arginine-specific supramolecular ligand (CLR01) destroys enveloped viruses, including HIV, Ebola, and Zika virus, and remodels amyloid fibrils in semen that promote viral infection. Yet, it is unknown how CLR01 exerts these two distinct therapeutic activities. Here, we delineate a novel mechanism of antiviral activity by studying the activity of tweezer variants: the “phosphate tweezer” CLR01, a “carboxylate tweezer” CLR05, and a “phosphate clip” PC. Lysine complexation inside the tweezer cavity is needed to antagonize amyloidogenesis and is only achieved by CLR01. Importantly, CLR01 and CLR05 but not PC form closed inclusion complexes with lipid head groups of viral membranes, thereby altering lipid orientation and increasing surface tension. This process disrupts viral envelopes and diminishes infectivity but leaves cellular membranes intact. Consequently, CLR01 and CLR05 display broad antiviral activity against all enveloped viruses tested, including herpesviruses, Measles virus, influenza, and SARS-CoV-2. Based on our mechanistic insights, we potentiated the antiviral, membrane-disrupting activity of CLR01 by introducing aliphatic ester arms into each phosphate group to act as lipid anchors that promote membrane targeting. The most potent ester modifications harbored unbranched C4 units, which engendered tweezers that were approximately one order of magnitude more effective than CLR01 and nontoxic. Thus, we establish the mechanistic basis of viral envelope disruption by specific tweezers and establish a new class of potential broad-spectrum antivirals with enhanced activity.Funding Information
- National Institute of Child Health and Human Development (R21HD074510)
- Deutsche Forschungsgemeinschaft (CRC 1093, CRC1279, EXC-2033-390677874)
- Bill and Melinda Gates Foundation
- National Institute on Aging (R01AG050721)
- H2020 Health (101003555)
- Boehringer Ingelheim Stiftung
- Baden-W?rttemberg Stiftung
- National Institute on Minority Health and Health Disparities (R21HD074510)
- Volkswagen Foundation
- Medizinische Fakult?t, Universit?t Ulm
This publication has 46 references indexed in Scilit:
- The Surprising Role of Amyloid Fibrils in HIV InfectionBiology, 2012
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01ACS Chemical Neuroscience, 2012
- A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in VivoNeurotherapeutics, 2012
- Naturally Occurring Fragments from Two Distinct Regions of the Prostatic Acid Phosphatase Form Amyloidogenic Enhancers of HIV InfectionJournal of Virology, 2012
- Peptides Released by Physiological Cleavage of Semen Coagulum Proteins Form Amyloids that Enhance HIV InfectionCell Host & Microbe, 2011
- Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid ProteinsJournal of the American Chemical Society, 2011
- Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cellsProceedings of the National Academy of Sciences, 2010
- Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped virusesProceedings of the National Academy of Sciences, 2010
- The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus InfectionJournal of Virology, 2009
- Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in PhosphoinositidesJournal of Virology, 2008